LAB
Standard Biotools Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
+2.04%
vs ±41.1% implied · ×0.05
shaded = implied · ▲▼ = realized
Largest filed tie
0
filed ties
Standard Biotools Inc.
0.61
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Casdin CapitalCasdin Capital | $73.0M | 29.98% | 0.00% | |
| 2 | Viking Global InvestorsViking Global Investors | $48.3M | 19.80% | 0.00% | |
| 3 | MAK Capital OneMAK Capital One | $23.7M | 9.73% | +10.09% | |
| 4 | Long Focus Capital ManagementLong Focus | $19.3M | 7.93% | +46.73% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $10.1M | 4.14% | −4.39% | |
| 6 | BlackRockBlackRockindex-like | $6.8M | 2.79% | −66.66% | |
| 7 | Hollow Brook Wealth ManagementHollow Brook Wealth | $4.5M | 1.86% | −2.65% | |
| 8 | Neuberger Berman GroupNeuberger Berman | $4.0M | 1.66% | +6.46% | |
| 9 | Qube Research & TechnologiesQube Research & Technologies | $4.0M | 1.63% | +584.33% | |
| 10 | Royce & AssociatesRoyce & | $3.7M | 1.53% | +50.57% | |
| 11 | Geode Capital ManagementGeodeindex-like | $3.2M | 1.32% | −46.54% | |
| 12 | Tikvah ManagementTikvah | $2.9M | 1.20% | 0.00% | |
| 13 | Millennium ManagementMillennium | $2.9M | 1.19% | +67.11% | |
| 14 | Morgan StanleyMorgan Stanley | $2.3M | 0.96% | −1.92% | |
| 15 | D. E. ShawD. E. Shaw | $2.3M | 0.95% | +1315.50% | |
| 16 | Jane Street GroupJane Street | $2.1M | 0.85% | new | |
| 17 | Peapod Lane CapitalPeapod Lane Capital | $2.0M | 0.81% | +18.88% | |
| 18 | Citadel AdvisorsCitadel | $2.0M | 0.80% | +87.38% | |
| 19 | Mink Brook Asset ManagementMink Brook | $1.8M | 0.74% | new | |
| 20 | Sone Capital ManagementSone | $1.8M | 0.72% | +20.76% | |
| 21 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $1.6M | 0.67% | new | |
| 22 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $1.6M | 0.64% | −1.44% | |
| 23 | Charles Schwab Investment ManagementCharles Schwabindex-like | $1.4M | 0.59% | −27.15% | |
| 24 | Jacobs Levy Equity ManagementJacobs Levy Equity | $1.3M | 0.55% | new | |
| 25 | State StreetState Streetindex-like | $1.3M | 0.52% | −76.47% |
141 managers report $243.7M of Standard Biotools on form 13F for the quarter ended Jun 30 '26. 10 of them hold 80% of it; Casdin Capital is largest at 29.98%.
Expected move
No implied move.
No implied move.
No implied move.